Essential Resources for Curated Immune Markers and Antibody Panels in Cytometry Analysis

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
Full text 45,083 characters · extracted from preprint-html · click to expand
Essential Resources for Curated Immune Markers and Antibody Panels in Cytometry Analysis | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Essential Resources for Curated Immune Markers and Antibody Panels in Cytometry Analysis Seongyun Choi , Jaeho Ji , Eunjeong Han , Ahrum Son , View ORCID Profile Hyunsoo Kim doi: https://doi.org/10.1101/2025.10.13.682059 Seongyun Choi 1 Department of Convergent Bioscience and Informatics, Chungnam National University , 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Republic of Korea Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jaeho Ji 2 Graduate School of Life Sciences, Chungnam National University , Daejeon 34134, Republic of Korea Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eunjeong Han 2 Graduate School of Life Sciences, Chungnam National University , Daejeon 34134, Republic of Korea Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ahrum Son 3 Graduate School of Medical Science, University of Ulsan , Ulsan 44610, Republic of Korea Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: kimlab{at}cnu.ac.kr ahson{at}ulsan.ac.kr Hyunsoo Kim 1 Department of Convergent Bioscience and Informatics, Chungnam National University , 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Republic of Korea 2 Graduate School of Life Sciences, Chungnam National University , Daejeon 34134, Republic of Korea 4 Department of Bio-AI Convergence, Chungnam National University , Daejeon 34134, Republic of Korea 5 Protein Design Institute, Chungnam National University , Daejeon 34134, Republic of Korea 6 SCICS , Daejeon 34134, Republic of Korea Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hyunsoo Kim For correspondence: kimlab{at}cnu.ac.kr ahson{at}ulsan.ac.kr Abstract Full Text Info/History Metrics Supplementary material Preview PDF Abstract The immune system, fundamental to numerous biological research fields, is increasingly investigated at single-cell resolution using high-dimensional flow cytometry and mass cytometry technologies. These approaches require comprehensive immunomarker information and carefully designed antibody panels that address the technical challenges of isotopic and spectral overlap inherent in metal/fluorescent-labeled antibodies. While immune cell markers have been extensively characterized and systematically catalogued, antibody panel information remains fragmented across the literature. To bridge this critical gap, we present ImapDB (Immune cell Marker and Panel Database), a novel Python-based graphical user interface that consolidates curated information on cell markers and antibody panels. ImapDB integrates data from commercial guidebooks, peer-reviewed literature, and validated research sources, currently focusing on normal human immune cell states. The database encompasses 127 distinct immune cell subtypes with over 350 validated markers and includes 45 commercial and 23 custom research antibody panels. Available on GitHub ( https://github.com/kimlab-cnu/Cell_Marker_GUI ), ImapDB serves as a centralized repository designed to streamline immune profiling assays and enhance research efficiency. Introduction Cytology has evolved from traditional microscopic examination of individual cells to encompass sophisticated single-cell analysis technologies across diverse research domains including pathology, oncology, proteomics, and transcriptomics [ 1 , 2 ]. These technological advances have been particularly transformative in immunology, enabling unprecedented insights into immune system complexity. Recent applications of single-cell approaches have revealed novel immune cell subtypes in cancer immunotherapy responses, such as the identification of exhausted CD8+ T cell populations that predict checkpoint inhibitor efficacy, and have uncovered previously unknown developmental trajectories in autoimmune diseases including the discovery of pathogenic T helper cell populations in multiple sclerosis [ 3 ]. Central to these advances are flow cytometry (FACS, Fluorescence-Activated Cell Sorting) and mass cytometry (CyTOF, Cytometry by Time-Of-Flight), which enable precise characterization of immune cell populations through multi-parametric analysis capable of simultaneously measuring up to 50 parameters per cell [ 3 ]. Immune cells, broadly categorized as myeloid cells and lymphocytes, express distinctive protein markers on their surface, intracellularly, and as secreted factors [ 4 ]. These markers serve as molecular signatures for cell identity; for instance, CD3 defines T lymphocytes, CD19 identifies B cells, CD14 marks classical monocytes, and CD56 characterizes natural killer cells. The expression patterns of these markers dynamically change throughout cell differentiation, activation states, and in response to environmental stimuli, making their systematic organization essential for accurate immunological studies [ 5 ]. Multi-marker analysis requires carefully designed antibody panels or cocktails comprising multiple antibodies that can simultaneously detect various cellular markers. The interpretation of co-expression patterns provides crucial insights into cell identity and functional states. For example, the combination of CD3+CD4+CD25+CD127low identifies regulatory T cells, while CD3+CD8+PD-1+TIM-3+ marks exhausted cytotoxic T cells [ 6 - 8 ]. However, panel design presents significant technical challenges, particularly in managing interference effects between metal isotopes in mass cytometry, where signal spillover can exceed 2% between adjacent channels, or fluorescence spectral overlap in flow cytometry, where compensation requirements can limit the number of usable fluorophore combinations [ 9 , 10 ]. Current approaches to panel design rely predominantly on commercial tools with limited flexibility or institutional services that may not accommodate specialized research needs. While commercial panels offer standardized solutions, researchers frequently require custom configurations tailored to specific biological questions. The design process demands comprehensive knowledge of marker expression patterns, antibody performance characteristics, and platform-specific technical considerations [ 11 ]. Despite the critical importance of panel optimization, no comprehensive resource currently integrates marker information with validated antibody configurations. We developed ImapDB to address this gap by providing a unified platform that combines systematic marker organization with curated antibody panel information. This Python-based graphical user interface consolidates data from authoritative sources, offering researchers immediate access to validated protocols and enabling informed experimental design. By bridging the gap between theoretical marker knowledge and practical implementation, ImapDB facilitates standardized approaches to immune profiling while supporting innovative applications in immunological research. Materials and Methods Software Architecture and Development ImapDB was developed as a Python-based application utilizing PyQt5 for graphical interface implementation and Qt Designer for interface layout. The software architecture employs a modular design with separate components for data management, user interface, and file input/output operations. Data processing capabilities were implemented using Pandas for efficient manipulation of tabular data, while openpyxl provides compatibility with Excel formats commonly used in laboratory workflows ( Figure 1 ) . Download figure Open in new tab Figure 1. Overview of ImapDB architecture and workflow. The database integrates immune cell marker information with antibody panel configurations through a Python-based graphical user interface, providing hierarchical navigation and comprehensive search capabilities. System Requirements and Installation The application operates on Windows, macOS, and Linux platforms with Python 3.6 or higher. Required dependencies include PyQt5 (installation via pip install pyqt5 and pip install pyqt5-tools), Pandas (pip install pandas), and openpyxl (pip install openpyxl). Following dependency installation, users can download the complete package from our GitHub repository. Path configuration may be required to ensure proper file loading, with detailed instructions provided in the documentation. Database Structure and Navigation ImapDB implements a four-module architecture comprising a main navigation window and three specialized interfaces for immune markers, CyTOF panels, and FACS panels ( Figure 2 ) . The hierarchical organization facilitates intuitive navigation through cascading selection menus that reflect biological relationships between cell populations. The Immune Dialog enables marker searches through three-tier selection: lineage (Lymphocyte/Myeloid), cell type, and subpopulation. Panel interfaces distinguish between commercial and experimental resources, each accessible through dedicated selection buttons ( Figure 3 ) . Download figure Open in new tab Figure 2. Hierarchical navigation interface for immune cell marker identification in ImapDB. (A) Main application window displaying three functional modules for accessing immune cell markers, CyTOF antibody panels, and FACS antibody panels. (B) Navigation pathway from the main window to the Immune Cell Marker Dialog through button selection. (C) Three-tier hierarchical selection system demonstrating marker identification for regulatory T cells, with sequential selection of cell lineage (Lymphocyte), cell type (CD4+ T cell), and subpopulation (Regulatory T cell). The resulting marker profile is displayed in tabular format below the selection interface. Download figure Open in new tab Figure 3. Antibody panel selection interface for mass cytometry applications in ImapDB. (A) Main window showing access points for cytometry-specific panel databases. (B) Navigation to the CyTOF Antibody Panel Dialog interface. (C) Panel selection interface featuring dual access modes for commercial and experimental panels. The example demonstrates retrieval of a commercial CyTOF panel with complete antibody specifications displayed in the table widget. Panel information includes marker targets, metal conjugates, and source references accessible through integrated DOI links. Data Curation and Sources Immune cell marker information was systematically compiled from commercial immunology guidebooks (Thermo Fisher, BD Biosciences, Invitrogen) and peer-reviewed literature [ 12 - 36 ]. Markers are categorized by expression pattern (surface/intracellular) and cellular lineage, with secreted markers excluded from the current version ( Table 1, Supplementary Table 1 ). Antibody panel data encompasses both commercial products and custom research configurations documented in publications [ 37 - 58 ]. Each panel entry includes complete marker composition, clone information where available, and source documentation through catalog numbers or digital object identifiers ( Table 2, Supplementary Table 2 ). This dual approach ensures coverage of standardized commercial solutions alongside innovative custom panels developed for specialized applications. Results Comprehensive Database of Human Immune Cell Markers ImapDB provides curated marker information for human immune cell populations in their normal physiological state, encompassing both lymphoid and myeloid lineages ( Figure 1 ) . The lymphoid compartment includes detailed profiles for T cells, B cells, and NK cells, with further subdivision into functionally distinct subsets. T cell populations span naive, memory, effector, and regulatory subsets, each annotated with lineage-defining and activation-associated markers. B cell categories cover developmental stages from progenitors to plasma cells, while NK cell subsets include both CD56bright and CD56dim populations. The myeloid compartment comprises monocyte subsets (classical, intermediate, and non-classical), dendritic cell populations (conventional and plasmacytoid), and granulocyte lineages including neutrophils, eosinophils, basophils, and mast cells (Table 1) . Each cell population entry provides comprehensive marker information organized in tabular format for rapid reference. Surface markers accessible for live cell analysis are distinguished from intracellular markers requiring fixation and permeabilization. This systematic organization enables researchers to identify appropriate marker combinations for their specific experimental objectives while understanding the technical requirements for detection (Supplementary Table 1) . Curated Repository of Antibody Panels The antibody panel database integrates commercial products with custom research configurations, providing researchers with diverse options for experimental design. Commercial panels from major vendors offer validated solutions for common applications, ranging from basic lineage identification to comprehensive immune profiling. These standardized panels have undergone rigorous quality control and provide consistent performance across different sample types. Custom research panels extracted from peer-reviewed publications demonstrate innovative approaches to specialized biological questions, often incorporating novel marker combinations or optimized protocols for challenging applications ( Table 2 ). Panel documentation includes complete antibody specifications with clone information, conjugate details, and recommended concentrations where available. Each entry links to source documentation through catalog numbers for commercial panels or DOIs for published protocols, enabling researchers to access detailed methodology and validation data. This comprehensive approach facilitates both direct adoption of existing panels and informed modification for specific research needs ( Supplementary Table 2 ). User Interface and Functional Features The ImapDB interface implements intuitive navigation through hierarchical menus that mirror conventional gating strategies used in cytometry analysis ( Figure 2 ). Users searching for specific cell markers proceed through sequential selection of lineage, cell type, and subpopulation, with each level dynamically updating based on previous selections. For example, identifying markers for regulatory CD8+ T cells involves selecting Lymphocyte → CD8+ T cell → Regulatory T cell (Treg), after which relevant markers are displayed in tabular format. Antibody panel searches utilize separate interfaces for CyTOF and FACS applications, acknowledging the distinct technical requirements of each platform ( Figure 3 ). Within each interface, users can toggle between commercial and experimental panels through clearly labeled buttons. The “Company panel” option provides access to vendor-validated products, while “Experimental panel” reveals custom configurations from research literature. Selection of “Total” from the combo box displays all available panels, enabling comprehensive comparison of different approaches. The table widget presents complete panel information including all markers, conjugates, and source references, with DOI links providing direct access to primary publications. Discussion ImapDB addresses a fundamental challenge in modern immunology by bridging the gap between theoretical knowledge of immune markers and practical implementation of cytometry experiments. The proliferation of single-cell technologies has revealed unprecedented cellular heterogeneity, yet this complexity creates barriers to experimental design, particularly for researchers entering the field or expanding into new biological systems. By providing an integrated platform that combines marker information with validated antibody panels, ImapDB democratizes access to advanced immunophenotyping techniques while promoting standardization across laboratories. The hierarchical organization of the database reflects careful consideration of how immunologists conceptualize cellular relationships and design experiments. Rather than presenting markers as isolated entities, ImapDB preserves biological context through its navigation structure, facilitating both education and practical application. The distinction between commercial and custom panels acknowledges that different research contexts require different solutions—standardized panels for clinical studies demanding reproducibility, and innovative custom panels for exploratory research pushing methodological boundaries. A key strength of ImapDB lies in its curation approach, which combines authoritative commercial resources with peer-reviewed research literature. This dual strategy ensures both breadth of coverage and depth of innovation. Commercial sources provide standardized definitions widely accepted in the field, while research publications contribute cutting-edge approaches that may not yet be commercially available. The requirement for literature support maintains scientific rigor while providing researchers with primary sources for detailed protocols beyond what can be captured in database fields. The current version of ImapDB represents a foundation for continued development and expansion. While focusing on normal human immune cells provides essential baseline information, we recognize that disease states often alter marker expression patterns significantly. Future iterations will incorporate disease-specific profiles, beginning with well-characterized conditions where extensive phenotyping data exists. Additionally, integration with emerging technologies such as spectral flow cytometry and single-cell RNA sequencing will enhance the database’s utility as these platforms become more prevalent. Technical sustainability relies on the open-source distribution model, which enables community contributions while maintaining quality through version control and curation standards. Regular updates through GitHub ensure the database remains current with evolving immunological knowledge, while user feedback drives feature development and content expansion. The familiar Excel-like interface and standard file formats facilitate adoption without requiring specialized training, removing barriers to access for the global research community. The impact of ImapDB extends beyond individual experiments to influence broader research practices. By promoting the use of validated panels and standardized marker sets, the database enhances reproducibility—a critical concern in immunological research. The educational value for trainees learning cytometry techniques cannot be overstated, as exposure to diverse panel designs accelerates understanding of both technical principles and biological applications. Furthermore, the aggregation of panel information may reveal patterns in marker usage that inform future reagent development and technology advancement. In conclusion, ImapDB provides essential infrastructure for modern immunological research by consolidating fragmented resources into an accessible, comprehensive platform. The database facilitates experimental design, promotes standardization, and accelerates research progress by eliminating redundant optimization efforts. As the complexity of immune profiling continues to increase, resources like ImapDB become increasingly vital for translating technological capabilities into biological insights. Through continued development and community engagement, ImapDB will evolve to meet emerging challenges while maintaining its core mission of democratizing access to advanced immunophenotyping techniques. Data Availability All data and software are freely available at https://github.com/kimlab-cnu/Cell_Marker_GUI under MIT license. The repository includes complete database files, source code, documentation, and installation guides. Author Contributions S.C., J.J.: conceptualization, data analysis, visualization; E.H.: data analysis; A.S., H.K.: conceptualization, methodology, project administration, funding acquisition, supervision, writing-review & editing. All authors reviewed and approved the final manuscript. Conflicts of Interest The authors declare no conflicts of interest. Tables Table 1. Summary of immune cell populations and marker categories in ImapDB. Table 2. Overview of antibody panels included in the database. Supplementary Materials Supplementary Table 1. Complete immune cell marker database with source references. Supplementary Table 2. Detailed antibody panel specifications with validation information. Acknowledgements This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (RS-2023-00209456) and the Korea Basic Science Institute (National Research Facilities and Equipment Center) grant funded by the Korean government (MSIT) (RS-2024-00402298). We acknowledge the use of Claude Opus 4.1 solely for linguistic refinement and grammatical corrections in manuscript preparation. All scientific content, data analysis, and intellectual contributions presented herein were developed independently by the authors without the use of generative AI tools. Figure 1 was created with BioRender.com . Funder Information Declared National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) , RS-2023-00209456 Korea Basic Science Institute (National Research Facilities and Equipment Center) grant funded by the Korean government (MSIT) , RS-2024-00402298 References 1. ↵ Gohil SH , Iorgulescu JB , Braun DA , Keskin DB , Livak KJ . Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy . Nat Rev Clin Oncol . 2021 ; 18 ( 4 ): 244 – 56 . Epub 20201204. doi: 10.1038/s41571-020-00449-x . PubMed PMID: 33277626 ; PubMed Central PMCID: PMCPMC8415132 . OpenUrl CrossRef PubMed 2. ↵ Gavasso S , Gullaksen SE , Skavland J , Gjertsen BT . Single-cell proteomics: potential implications for cancer diagnostics . Expert Rev Mol Diagn . 2016 ; 16 ( 5 ): 579 – 89 . Epub 20160321. doi: 10.1586/14737159.2016.1156531 . PubMed PMID: 26895397 . OpenUrl CrossRef PubMed 3. ↵ Spitzer MH , Nolan GP . Mass Cytometry: Single Cells, Many Features . Cell . 2016 ; 165 ( 4 ): 780 – 91 . doi: 10.1016/j.cell.2016.04.019 . PubMed PMID: 27153492 ; PubMed Central PMCID: PMCPMC4860251 . OpenUrl CrossRef PubMed 4. ↵ Moser M , Leo O. Key concepts in immunology . Vaccine . 2010 ; 28 Suppl 3 : C2 - 13 . doi: 10.1016/j.vaccine.2010.07.022 . PubMed PMID: 20713253 . OpenUrl CrossRef PubMed Web of Science 5. ↵ De la Fuente M , Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging . Curr Pharm Des . 2009 ; 15 ( 26 ): 3003 – 26 . doi: 10.2174/138161209789058110 . PubMed PMID: 19754376 . OpenUrl CrossRef PubMed Web of Science 6. ↵ Ferrer-Font L , Small SJ , Lewer B , Pilkington KR , Johnston LK , Park LM , et al. Panel Optimization for High-Dimensional Immunophenotyping Assays Using Full-Spectrum Flow Cytometry . Curr Protoc . 2021 ; 1 ( 9 ): e222 . doi: 10.1002/cpz1.222 . PubMed PMID: 34492732 . OpenUrl CrossRef PubMed 7. Ozanska A , Szymczak D , Rybka J. Pattern of human monocyte subpopulations in health and disease . Scand J Immunol . 2020 ; 92 ( 1 ): e12883 . Epub 20200505. doi: 10.1111/sji.12883 . PubMed PMID: 32243617 . OpenUrl CrossRef PubMed 8. ↵ Severin Y , Hale BD , Mena J , Goslings D , Frey BM , Snijder B. Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypes . Sci Adv . 2022 ; 8 ( 44 ): eabn5631 . Epub 20221102. doi: 10.1126/sciadv.abn5631 . PubMed PMID: 36322666 ; PubMed Central PMCID: PMCPMC9629716 . OpenUrl CrossRef PubMed 9. ↵ Takahashi C , Au-Yeung A , Fuh F , Ramirez-Montagut T , Bolen C , Mathews W , et al. Mass cytometry panel optimization through the designed distribution of signal interference . Cytom Part A . 2017 ; 91a ( 1 ): 39 – 47 . doi: 10.1002/cyto.a.22977 . PubMed PMID: WOS:000395401200006 . OpenUrl CrossRef PubMed 10. ↵ Park LM , Lannigan J , Jaimes MC . OMIP-069: Forty-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood . Cytom Part A . 2020 ; 97 ( 10 ): 1044 – 51 . doi: 10.1002/cyto.a.24213 . PubMed PMID: WOS:000564027800001 . OpenUrl CrossRef PubMed 11. ↵ Ferrer-Font L , Pellefigues C , Mayer JU , Small SJ , Jaimes MC , Price KM . Panel Design and Optimization for High-Dimensional Immunophenotyping Assays Using Spectral Flow Cytometry . Curr Protoc Cytom . 2020 ; 92 ( 1 ): e70 . doi: 10.1002/cpcy.70 . PubMed PMID: 32150355 . OpenUrl CrossRef PubMed 12. ↵ Rappolee DA , Mark D , Banda MJ , Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping . Science . 1988 ; 241 ( 4866 ): 708 – 12 . doi: 10.1126/science.3041594 . PubMed PMID: 3041594 . OpenUrl Abstract / FREE Full Text 13. Broudy VC . Stem cell factor and hematopoiesis . Blood . 1997 ; 90 ( 4 ): 1345 - 64 . PubMed PMID: 9269751 . OpenUrl FREE Full Text 14. Blasi F , Carmeliet P. uPAR: a versatile signalling orchestrator . Nat Rev Mol Cell Biol . 2002 ; 3 ( 12 ): 932 – 43 . doi: 10.1038/nrm977 . PubMed PMID: 12461559 . OpenUrl CrossRef PubMed Web of Science 15. Hamann J , Koning N , Pouwels W , Ulfman LH , van Eijk M , Stacey M , et al. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor . Eur J Immunol . 2007 ; 37 ( 10 ): 2797 – 802 . doi: 10.1002/eji.200737553 . PubMed PMID: WOS:000250294100015 . OpenUrl CrossRef PubMed 16. Trivedi SG , Lloyd CM . Eosinophils in the pathogenesis of allergic airways disease . Cell Mol Life Sci . 2007 ; 64 ( 10 ): 1269 – 89 . doi: 10.1007/s00018-007-6527-y . PubMed PMID: WOS:000246617400011 . OpenUrl CrossRef PubMed 17. Tippett E , Cheng WJ , Westhorpe C , Cameron PU , Brew BJ , Lewin SR , et al. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals . Plos One . 2011 ; 6 ( 5 ): e19968 . Epub 20110520. doi: 10.1371/journal.pone.0019968 . PubMed PMID: 21625498 ; PubMed Central PMCID: PMCPMC3098854 . OpenUrl CrossRef PubMed 18. Dinarello CA , Novick D , Kim S , Kaplanski G. Interleukin-18 and IL-18 binding protein . Front Immunol . 2013 ; 4 : 289 . Epub 20131008. doi: 10.3389/fimmu.2013.00289 . PubMed PMID: 24115947 ; PubMed Central PMCID: PMCPMC3792554 . OpenUrl CrossRef PubMed 19. Chavez-Galan L , Olleros ML , Vesin D , Garcia I. Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages . Front Immunol . 2015 ; 6 : 263 . Epub 20150526. doi: 10.3389/fimmu.2015.00263 . PubMed PMID: 26074923 ; PubMed Central PMCID: PMCPMC4443739 . OpenUrl CrossRef PubMed 20. Golubovskaya V , Wu L. Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy . Cancers (Basel) . 2016 ; 8 ( 3 ). Epub 20160315. doi: 10.3390/cancers8030036 . PubMed PMID: 26999211 ; PubMed Central PMCID: PMCPMC4810120 . OpenUrl CrossRef PubMed 21. Ustun C , Arock M , Kluin-Nelemans HC , Reiter A , Sperr WR , George T , et al. Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice . Haematologica . 2016 ; 101 ( 10 ): 1133 – 43 . doi: 10.3324/haematol.2016.146563 . PubMed PMID: WOS:000392548700015 . OpenUrl Abstract / FREE Full Text 22. García-Roa M , Vicente-Ayuso MD , Bobes AM , Pedraza AC , González-Fernández A , Martín MP , et al. Red blood cell storage time and transfusion: current practice, concerns and future perspectives . Blood Transfus-Italy . 2017 ; 15 ( 3 ): 222 – 31 . doi: 10.2450/2017.0345-16 . PubMed PMID: WOS:000400682100006 . OpenUrl CrossRef PubMed 23. Hussen J , Schuberth HJ . Heterogeneity of Bovine Peripheral Blood Monocytes . Front Immunol . 2017 ; 8 : 1875 . Epub 20171219. doi: 10.3389/fimmu.2017.01875 . PubMed PMID: 29312348 ; PubMed Central PMCID: PMCPMC5742132 . OpenUrl CrossRef PubMed 24. Ma CS , Tangye SG . Flow Cytometric-Based Analysis of Defects in Lymphocyte Differentiation and Function Due to Inborn Errors of Immunity . Front Immunol . 2019 ; 10 : 2108 . Epub 20190904. doi: 10.3389/fimmu.2019.02108 . PubMed PMID: 31552044 ; PubMed Central PMCID: PMCPMC6737833 . OpenUrl CrossRef PubMed 25. Patel KR , Roberts JT , Barb AW . Multiple Variables at the Leukocyte Cell Surface Impact Fc gamma Receptor-Dependent Mechanisms . Front Immunol . 2019 ; 10 : 223 . Epub 20190214. doi: 10.3389/fimmu.2019.00223 . PubMed PMID: 30837990 ; PubMed Central PMCID: PMCPMC6382684 . OpenUrl CrossRef PubMed 26. Rhodes JW , Tong O , Harman AN , Turville SG . Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection . Front Immunol . 2019 ; 10 : 1088 . Epub 20190516. doi: 10.3389/fimmu.2019.01088 . PubMed PMID: 31156637 ; PubMed Central PMCID: PMCPMC6532592 . OpenUrl CrossRef PubMed 27. Richards CD , Botelho F. Oncostatin M in the Regulation of Connective Tissue Cells and Macrophages in Pulmonary Disease . Biomedicines . 2019 ; 7 ( 4 ). Epub 20191205. doi: 10.3390/biomedicines7040095 . PubMed PMID: 31817403 ; PubMed Central PMCID: PMCPMC6966661 . OpenUrl CrossRef PubMed 28. Sutton TL , Walker BS , Wong MH . Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers . Cell Mol Gastroenter . 2019 ; 8 ( 4 ): 595 – 607 . doi: 10.1016/j.jcmgh.2019.07.002 . PubMed PMID: WOS:000498888000005 . OpenUrl CrossRef PubMed 29. Bennett ML , Bennett FC . The influence of environment and origin on brain resident macrophages and implications for therapy . Nat Neurosci . 2020 ; 23 ( 2 ): 157 – 66 . Epub 20191202. doi: 10.1038/s41593-019-0545-6 . PubMed PMID: 31792468 . OpenUrl CrossRef PubMed 30. Blair TA , Frelinger AL . Platelet surface marker analysis by mass cytometry . Platelets . 2020 ; 31 ( 5 ): 633 – 40 . doi: 10.1080/09537104.2019.1668549 . PubMed PMID: WOS:000487294100001 . OpenUrl CrossRef PubMed 31. Terpstra ML , Remmerswaal EBM , van der Bom-Baylon ND , Sinnige MJ , Kers J , van Aalderen MC , et al. Tissue-resident mucosal-associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset . Eur J Immunol . 2020 ; 50 ( 11 ): 1783 – 97 . doi: 10.1002/eji.202048644 . PubMed PMID: WOS:000555889000001 . OpenUrl CrossRef PubMed 32. Willemsen L , de Winther MPJ . Macrophage subsets in atherosclerosis as defined by single-cell technologies . J Pathol . 2020 ; 250 ( 5 ): 705 – 14 . doi: 10.1002/path.5392 . PubMed PMID: WOS:000529190600019 . OpenUrl CrossRef PubMed 33. McKenna E , Mhaonaigh AU , Wubben R , Dwivedi A , Hurley T , Kelly LA , et al. Neutrophils: Need for Standardized Nomenclature . Front Immunol . 2021 ; 12 : 602963 . Epub 20210415. doi: 10.3389/fimmu.2021.602963 . PubMed PMID: 33936029 ; PubMed Central PMCID: PMCPMC8081893 . OpenUrl CrossRef PubMed 34. Wang H , He J , Xu C , Chen X , Yang H , Shi S , et al. Decoding Human Megakaryocyte Development . Cell Stem Cell . 2021 ; 28 ( 3 ): 535 – 49 e8 . Epub 20201218. doi: 10.1016/j.stem.2020.11.006 . PubMed PMID: 33340451 . OpenUrl CrossRef PubMed 35. Mantovani A , Allavena P , Marchesi F , Garlanda C. Macrophages as tools and targets in cancer therapy . Nat Rev Drug Discov . 2022 ; 21 ( 11 ): 799 – 820 . doi: 10.1038/s41573-022-00520-5 . PubMed PMID: WOS:000841060700001 . OpenUrl CrossRef PubMed 36. ↵ Morgan D , Tergaonkar V. Unraveling B cell trajectories at single cell resolution . Trends Immunol . 2022 ; 43 ( 3 ): 210 – 29 . doi: 10.1016/j.it.2022.01.003 . PubMed PMID: WOS:000762104100008 . OpenUrl CrossRef PubMed 37. ↵ Finak G , Langweiler M , Jaimes M , Malek M , Taghiyar J , Korin Y , et al. Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium . Sci Rep . 2016 ; 6 : 20686 . Epub 20160210. doi: 10.1038/srep20686 . PubMed PMID: 26861911 ; PubMed Central PMCID: PMCPMC4748244 . OpenUrl CrossRef PubMed 38. Ruhle PF , Fietkau R , Gaipl US , Frey B. Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry . Int J Mol Sci . 2016 ; 17 ( 8 ). Epub 20160811. doi: 10.3390/ijms17081316 . PubMed PMID: 27529227 ; PubMed Central PMCID: PMCPMC5000713 . OpenUrl CrossRef PubMed 39. van Unen V , Li N , Molendijk I , Temurhan M , Höllt T , van der Meulen-de Jong AE , et al. Mass Cytometry of the Human Mucosal Immune System Identifies Tissue- and Disease-Associated Immune Subsets . Immunity . 2016 ; 44 ( 5 ): 1227 – 39 . doi: 10.1016/j.immuni.2016.04.014 . PubMed PMID: WOS:000376478500025 . OpenUrl CrossRef PubMed 40. Veluchamy JP , Delso-Vallejo M , Kok N , Bohme F , Seggewiss-Bernhardt R , van der Vliet HJ , et al. Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function . Sci Rep . 2017 ; 7 : 43873 . Epub 20170310. doi: 10.1038/srep43873 . PubMed PMID: 28281564 ; PubMed Central PMCID: PMCPMC5345017 . OpenUrl CrossRef PubMed 41. Gadalla R , Noamani B , MacLeod BL , Dickson RJ , Guo M , Xu W , et al. Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials . Front Oncol . 2019 ; 9 : 415 . Epub 20190517. doi: 10.3389/fonc.2019.00415 . PubMed PMID: 31165047 ; PubMed Central PMCID: PMCPMC6534060 . OpenUrl CrossRef PubMed 42. Good Z , Borges L , Gonzalez NV , Sahaf B , Samusik N , Tibshirani R , et al. Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells . Nat Biotechnol . 2019 ; 37 ( 3 ): 259 -+. doi: 10.1038/s41587-019-0033-2 . PubMed PMID: WOS:000460155900016 . OpenUrl CrossRef PubMed 43. Yang ZZ , Kim HJ , Villasboas JC , Price-Troska T , Jalali S , Wu H , et al. Mass Cytometry Analysis Reveals that Specific Intratumoral CD4(+) T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma . Cell Rep . 2019 ; 26 ( 8 ): 2178 – 93 e3 . doi: 10.1016/j.celrep.2019.01.085 . PubMed PMID: 30784598 ; PubMed Central PMCID: PMCPMC6402596 . OpenUrl CrossRef PubMed 44. Hanidziar D , Nakahori Y , Cahill LA , Gallo D , Keegan JW , Nguyen JP , et al. Characterization of pulmonary immune responses to hyperoxia by high-dimensional mass cytometry analyses . Sci Rep . 2020 ; 10 ( 1 ): 4677 . Epub 20200313. doi: 10.1038/s41598-020-61489-y . PubMed PMID: 32170168 ; PubMed Central PMCID: PMCPMC7070092 . OpenUrl CrossRef PubMed 45. Couloume L , Ferrant J , Le Gallou S , Mandon M , Jean R , Bescher N , et al. Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis . Front Immunol . 2021 ; 12 : 653577 . Epub 20210504. doi: 10.3389/fimmu.2021.653577 . PubMed PMID: 34017332 ; PubMed Central PMCID: PMCPMC8129576 . OpenUrl CrossRef PubMed 46. Fribourg M , Cioni M , Ghiggeri G , Cantarelli C , Leventhal JS , Budge K , et al. CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome . Front Immunol . 2021 ; 12 : 726428 . Epub 20210921. doi: 10.3389/fimmu.2021.726428 . PubMed PMID: 34621271 ; PubMed Central PMCID: PMCPMC8490633 . OpenUrl CrossRef PubMed 47. Kothari H , Williams CM , McSkimming C , Drago F , Marshall MA , Garmey J , et al. Identification of human immune cell subtypes most responsive to IL-1beta-induced inflammatory signaling using mass cytometry . Sci Signal . 2021 ; 14 ( 673 ). Epub 20210309. doi: 10.1126/scisignal.abc5763 . PubMed PMID: 33688079 ; PubMed Central PMCID: PMCPMC8491136 . OpenUrl Abstract / FREE Full Text 48. Levine LS , Hiam-Galvez KJ , Marquez DM , Tenvooren I , Madden MZ , Contreras DC , et al. Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8(+) T cells during the primary immune response . Immunity . 2021 ; 54 ( 4 ): 829 – 44 e5 . Epub 20210310. doi: 10.1016/j.immuni.2021.02.018 . PubMed PMID: 33705706 ; PubMed Central PMCID: PMCPMC8046726 . OpenUrl CrossRef PubMed 49. Spatz JM , Fulford MH , Tsai A , Gaudilliere D , Hedou J , Ganio E , et al. Human immune system adaptations to simulated microgravity revealed by single-cell mass cytometry . Sci Rep . 2021 ; 11 ( 1 ): 11872 . Epub 20210607. doi: 10.1038/s41598-021-90458-2 . PubMed PMID: 34099760 ; PubMed Central PMCID: PMCPMC8184772 . OpenUrl CrossRef PubMed 50. Wang WW , Li HB , Zhang LH , Jiang WL , Shen LS , Fan G. Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry . Int J Lab Hematol . 2021 ; 43 ( 5 ): 1132 – 44 . doi: 10.1111/ijlh.13541 . PubMed PMID: WOS:000640938400001 . OpenUrl CrossRef PubMed 51. Pedersen CB , Dam SH , Barnkob MB , Leipold MD , Purroy N , Rassenti LZ , et al. cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies . Nat Commun . 2022 ; 13 ( 1 ): 1698 . Epub 20220331. doi: 10.1038/s41467-022-29383-5 . PubMed PMID: 35361793 ; PubMed Central PMCID: PMCPMC8971492 . OpenUrl CrossRef PubMed 52. van der Pan K , de Bruin-Versteeg S , Damasceno D , Hernandez-Delgado A , van der Sluijs-Gelling AJ , van den Bossche WBL , et al. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood . Front Immunol . 2022 ; 13 : 935879 . Epub 20220914. doi: 10.3389/fimmu.2022.935879 . PubMed PMID: 36189252 ; PubMed Central PMCID: PMCPMC9519388 . OpenUrl CrossRef PubMed 53. Baughn LB , Jessen E , Sharma N , Tang H , Smadbeck JB , Long MD , et al. Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma . Blood Cancer J . 2023 ; 13 ( 1 ): 84 . Epub 20230522. doi: 10.1038/s41408-023-00851-5 . PubMed PMID: 37217482 ; PubMed Central PMCID: PMCPMC10203138 . OpenUrl CrossRef PubMed 54. Gao J , Luo YL , Li HL , Zhao YR , Zhao JL , Han XL , et al. Deep Immunophenotyping of Human Whole Blood by Standardized Multi-parametric Flow Cytometry Analyses . Phenomics . 2023 ; 3 ( 3 ): 309 – 28 . doi: 10.1007/s43657-022-00092-9 . PubMed PMID: WOS:001110872800004 . OpenUrl CrossRef PubMed 55. Heubeck A , Savage A , Henderson K , Roll C , Hernandez V , Torgerson T , et al. Cross-platform immunophenotyping of human peripheral blood mononuclear cells with four high-dimensional flow cytometry panels . Cytom Part A . 2023 ; 103 ( 6 ): 500 – 17 . doi: 10.1002/cyto.a.24715 . PubMed PMID: WOS:000913658500001 . OpenUrl CrossRef PubMed 56. Jin J , Wang L , Liu Y , He W , Zheng D , Ni Y , et al. Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry . Front Endocrinol (Lausanne) . 2022 ; 13 : 1018608 . Epub 20230106. doi: 10.3389/fendo.2022.1018608 . PubMed PMID: 36686486 ; PubMed Central PMCID: PMCPMC9853014 . OpenUrl CrossRef PubMed 57. Karacosta LG , Pancirer D , Preiss JS , Benson JA , Trope W , Shrager JB , et al. Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry . Sci Rep . 2023 ; 13 ( 1 ): 21781 . Epub 20231208. doi: 10.1038/s41598-023-46458-5 . PubMed PMID: 38065965 ; PubMed Central PMCID: PMCPMC10709404 . OpenUrl CrossRef PubMed 58. ↵ van der Pan K , Khatri I , de Jager AL , Louis A , Kassem S , Naber BAE , et al. Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations . Front Immunol . 2023 ; 14 : 1191992 . Epub 20230519. doi: 10.3389/fimmu.2023.1191992 . PubMed PMID: 37275858 ; PubMed Central PMCID: PMCPMC10235610 . OpenUrl CrossRef PubMed View the discussion thread. Back to top Previous Next Posted October 14, 2025. Download PDF Supplementary Material Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Essential Resources for Curated Immune Markers and Antibody Panels in Cytometry Analysis Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Essential Resources for Curated Immune Markers and Antibody Panels in Cytometry Analysis Seongyun Choi , Jaeho Ji , Eunjeong Han , Ahrum Son , Hyunsoo Kim bioRxiv 2025.10.13.682059; doi: https://doi.org/10.1101/2025.10.13.682059 Share This Article: Copy Citation Tools Essential Resources for Curated Immune Markers and Antibody Panels in Cytometry Analysis Seongyun Choi , Jaeho Ji , Eunjeong Han , Ahrum Son , Hyunsoo Kim bioRxiv 2025.10.13.682059; doi: https://doi.org/10.1101/2025.10.13.682059 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Bioinformatics Subject Areas All Articles Animal Behavior and Cognition (7618) Biochemistry (17635) Bioengineering (13859) Bioinformatics (41846) Biophysics (21401) Cancer Biology (18534) Cell Biology (25422) Clinical Trials (138) Developmental Biology (13352) Ecology (19860) Epidemiology (2067) Evolutionary Biology (24285) Genetics (15582) Genomics (22463) Immunology (17700) Microbiology (40298) Molecular Biology (17141) Neuroscience (88424) Paleontology (666) Pathology (2825) Pharmacology and Toxicology (4813) Physiology (7633) Plant Biology (15107) Scientific Communication and Education (2042) Synthetic Biology (4284) Systems Biology (9808) Zoology (2267)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00